CD4(+) and CD8a(+) PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models

Predicting the outcome of immunotherapy is essential for efficient treatment. The recent clinical success of immunotherapy is increasingly changing the paradigm of cancer treatment. Accordingly, the development of immune-based agents is accelerating and the number of agents in the global immuno-onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Lotte K., Fröhlich, Camilla, Christensen, Camilla, Melander, Maria C., Poulsen, Thomas T., Galler, Gunther R., Lantto, Johan, Horak, Ivan D., Kragh, Michael, Nielsen, Carsten H., Kjaer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857046/
https://www.ncbi.nlm.nih.gov/pubmed/31754392
http://dx.doi.org/10.7150/thno.37513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857046/
https://www.ncbi.nlm.nih.gov/pubmed/31754392
http://dx.doi.org/10.7150/thno.37513

Ejemplares similares